English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Johnson & Johnson halts mid-stage eczema drug trial after missing efficacy goal
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

FDA announces phase-out of mandatory animal tests for monoclonal antibody drug development
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Lilly targets record revenue as competition heats up over new oral obesity drugs
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Study links higher body weight to increased risk of low back pain
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Boston College team uses AI to greatly improve clarity of brain imaging data
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Income sufficiency linked to early childhood brain development in new study
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Columbia researchers develop inhalable nanotherapy for checkpoint-resistant melanoma
+ Pharmaceuticals
Patient Daily | Jan 15, 2026

Experts release new guidelines to help diagnose canine dementia

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes